Table 2.
|
|
n(%) |
|
|
|
---|---|---|---|---|---|
Model | Genotype | Cases (N = 229) | Controls (N = 357) | Crude OR (95 % CI) | Adjusted OR (95 % CI)* |
Co-dominant |
CC |
61 (26.6) |
96 (26.9) |
1.00 |
1.00 |
|
CA |
98 (42.8) |
183 (51.3) |
0.84 (0.56 − 1.26) |
0.85 (0.56 − 1.30) |
|
AA |
70 (30.6) |
78 (21.9) |
1.41 (0.90 − 2.23) |
1.41 (0.88 − 2.27) |
Additive |
|
|
|
1.19 (0.94 − 1.50) |
1.19 (0.94 − 1.51) |
Dominant |
|
|
|
1.01 (0.70 − 1.47) |
1.02 (0.69 − 1.51) |
Recessive | 1.57 (1.08 − 2.30) | 1.57 (1.06 − 2.31) |
*Adjusted for sex, age, region of residence, smoking, and caffeine intake.